Influenza virus a, california, 2009 v-l, victoria, 361, 2011, influenza virus b, wisconsin, 2010 (Influvac Subunit)
Influenza virus a, california, 2009 v-l, victoria, 361, 2011, influenza virus b, wisconsin, 2010
Abbott Laboratories S.A. (Pty) Ltd
Registration
- Applicant
- Abbott Laboratories S.A. (Pty) Ltd
- Certificate holder
- Abbott Laboratories South Africa (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Influvac subunit 2021 EACH 0,5 ml SYRINGE CONTAINS INFLUENZA VIRUS A/CALIFORNIA/7/2009(H1N1)V-L 15,0 ugINFLUENZA VIRUS A/VICTORIA/361/2011 (H3N2) 15,0 ugINFLUENZA VIRUS B/WISCONSIN/1/2010 15,0 ug | 15 μgSuspension for injection in prefilled syringe. | T0581T/30.1/581Approved 20 February 2024 | Registered | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.